# Effects of Ulinastatin on Myocardial Protection and Blood Loss in Patients Undergoing Aortic Valve Replacement

> **NCT00944385** · PHASE4 · COMPLETED · sponsor: **Yonsei University**

## Conditions studied

- Abnormal Aortic Valve

## Interventions

- **DRUG:** ulinastatin

## Key facts

- **NCT ID:** NCT00944385
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** — (—)
- **Last updated:** 2011-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00944385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00944385, "Effects of Ulinastatin on Myocardial Protection and Blood Loss in Patients Undergoing Aortic Valve Replacement". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00944385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*